APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Morpholine and Derivatives

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Morpholine and Derivatives Market Analysis and Forecast 2026-2032

Report ID 173313220224 December 2025207 pages

Choose your research edition.

Industry ResearchMorpholine and Derivatives Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Morpholine and Derivatives Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Morpholine and Derivatives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Morpholine and Derivatives Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Morpholine and Derivatives Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Morpholine and Derivatives market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Morpholine and Derivatives's global sales reached XX (Tons) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Huntsman as the global sales leader, a title it has maintained for several consecutive years. Notably, Huntsman's performance in primary markets is also remarkable. In the Chinese market, sales were XX (Tons), a change of XX% from the previous year. In Europe, sales were XX (Tons), showing a year-on-year of XX%. In the US, sales were XX (Tons), a year-on-year change of XX%.

The major global manufacturers in the Morpholine and Derivatives market include Huntsman, Anhui Wotu Chemical, BASF, Jiangsu Dingsheng Chemical, Liyang Yutian Chemical, Sichuan Institute of Fine Chemical, Jiangsu Lianrun Chemical, Nippon Nyukazai and Amines & Plasticizers, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Morpholine and Derivatives production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Morpholine and Derivatives by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Morpholine and Derivatives, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Morpholine and Derivatives, also provides the consumption of main regions and countries. Of the upcoming market potential for Morpholine and Derivatives, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Morpholine and Derivatives sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Morpholine and Derivatives market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Morpholine and Derivatives sales, projected growth trends, production technology, application and end-user industry.

Morpholine and Derivatives Segment by Company

Huntsman

Anhui Wotu Chemical

BASF

Jiangsu Dingsheng Chemical

Liyang Yutian Chemical

Sichuan Institute of Fine Chemical

Jiangsu Lianrun Chemical

Nippon Nyukazai

Amines & Plasticizers

Morpholine and Derivatives Segment by Type

Morpholine

N-ethylmorpholine

N-methylmorpholine

Other

Morpholine and Derivatives Segment by Application

Corrosion Inhibitor

Pesticide

Rubber

Pharmaceutical

Other

Morpholine and Derivatives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Morpholine and Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Morpholine and Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Morpholine and Derivatives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Morpholine and Derivatives production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Morpholine and Derivatives in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Morpholine and Derivatives manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Morpholine and Derivatives sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Morpholine and Derivatives Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Morpholine Major Manufacturers Table 3. N-ethylmorpholine Major Manufacturers Table 4. N-methylmorpholine Major Manufacturers Table 5. Other Major Manufacturers Table 6. Global Morpholine and Derivatives Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Corrosion Inhibitor Major Manufacturers Table 8. Pesticide Major Manufacturers Table 9. Rubber Major Manufacturers Table 10. Pharmaceutical Major Manufacturers Table 11. Other Major Manufacturers Table 12. Morpholine and Derivatives Industry Trends Table 13. Morpholine and Derivatives Industry Drivers Table 14. Morpholine and Derivatives Industry Opportunities and Challenges Table 15. Morpholine and Derivatives Industry Restraints Table 16. Global Morpholine and Derivatives Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 17. Global Morpholine and Derivatives Production by Region (2021-2026) & (Tons) Table 18. Global Morpholine and Derivatives Production by Region (2027-2032) & (Tons) Table 19. Global Morpholine and Derivatives Production Market Share by Region (2021-2026) Table 20. Global Morpholine and Derivatives Production Market Share by Region (2027-2032) Table 21. Global Morpholine and Derivatives Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 22. Global Morpholine and Derivatives Revenue by Region (2021-2026) & (US$ Million) Table 23. Global Morpholine and Derivatives Revenue by Region (2027-2032) & (US$ Million) Table 24. Global Morpholine and Derivatives Revenue Market Share by Region (2021-2026) Table 25. Global Morpholine and Derivatives Revenue Market Share by Region (2027-2032) Table 26. Global Morpholine and Derivatives Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 27. Global Morpholine and Derivatives Sales by Region (2021-2026) & (Tons) Table 28. Global Morpholine and Derivatives Sales by Region (2027-2032) & (Tons) Table 29. Global Morpholine and Derivatives Sales Market Share by Region (2021-2026) Table 30. Global Morpholine and Derivatives Sales Market Share by Region (2027-2032) Table 31. Global Morpholine and Derivatives Revenue by Manufacturers (US$ Million) & (2021-2026) Table 32. Global Morpholine and Derivatives Revenue Market Share by Manufacturers (2021-2026) Table 33. Global Morpholine and Derivatives Sales by Manufacturers (US$ Million) & (2021-2026) Table 34. Global Morpholine and Derivatives Sales Market Share by Manufacturers (2021-2026) Table 35. Global Morpholine and Derivatives Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 36. Global Morpholine and Derivatives Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 37. Global Morpholine and Derivatives Key Manufacturers Manufacturing Sites & Headquarters Table 38. Global Morpholine and Derivatives Manufacturers, Product Type & Application Table 39. Global Morpholine and Derivatives Manufacturers Commercialization Time Table 40. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 41. Global Morpholine and Derivatives by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 42. Global Morpholine and Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 43. Global Morpholine and Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 44. Global Morpholine and Derivatives Revenue Market Share by Type (2021-2026) Table 45. Global Morpholine and Derivatives Revenue Market Share by Type (2027-2032) Table 46. Global Morpholine and Derivatives Sales by Type (2021-2026) & (Tons) Table 47. Global Morpholine and Derivatives Sales by Type (2027-2032) & (Tons) Table 48. Global Morpholine and Derivatives Sales Market Share by Type (2021-2026) Table 49. Global Morpholine and Derivatives Sales Market Share by Type (2027-2032) Table 50. Global Morpholine and Derivatives Price by Type (2021-2026) & (US$/Ton) Table 51. Global Morpholine and Derivatives Price by Type (2027-2032) & (US$/Ton) Table 52. Global Morpholine and Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 53. Global Morpholine and Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 54. Global Morpholine and Derivatives Revenue Market Share by Application (2021-2026) Table 55. Global Morpholine and Derivatives Revenue Market Share by Application (2027-2032) Table 56. Global Morpholine and Derivatives Sales by Application (2021-2026) & (Tons) Table 57. Global Morpholine and Derivatives Sales by Application (2027-2032) & (Tons) Table 58. Global Morpholine and Derivatives Sales Market Share by Application (2021-2026) Table 59. Global Morpholine and Derivatives Sales Market Share by Application (2027-2032) Table 60. Global Morpholine and Derivatives Price by Application (2021-2026) & (US$/Ton) Table 61. Global Morpholine and Derivatives Price by Application (2027-2032) & (US$/Ton) Table 62. Huntsman Company Information Table 63. Huntsman Business Overview Table 64. Huntsman Morpholine and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 65. Huntsman Morpholine and Derivatives Product Portfolio Table 66. Huntsman Recent Development Table 67. Anhui Wotu Chemical Company Information Table 68. Anhui Wotu Chemical Business Overview Table 69. Anhui Wotu Chemical Morpholine and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 70. Anhui Wotu Chemical Morpholine and Derivatives Product Portfolio Table 71. Anhui Wotu Chemical Recent Development Table 72. BASF Company Information Table 73. BASF Business Overview Table 74. BASF Morpholine and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. BASF Morpholine and Derivatives Product Portfolio Table 76. BASF Recent Development Table 77. Jiangsu Dingsheng Chemical Company Information Table 78. Jiangsu Dingsheng Chemical Business Overview Table 79. Jiangsu Dingsheng Chemical Morpholine and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Jiangsu Dingsheng Chemical Morpholine and Derivatives Product Portfolio Table 81. Jiangsu Dingsheng Chemical Recent Development Table 82. Liyang Yutian Chemical Company Information Table 83. Liyang Yutian Chemical Business Overview Table 84. Liyang Yutian Chemical Morpholine and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. Liyang Yutian Chemical Morpholine and Derivatives Product Portfolio Table 86. Liyang Yutian Chemical Recent Development Table 87. Sichuan Institute of Fine Chemical Company Information Table 88. Sichuan Institute of Fine Chemical Business Overview Table 89. Sichuan Institute of Fine Chemical Morpholine and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Sichuan Institute of Fine Chemical Morpholine and Derivatives Product Portfolio Table 91. Sichuan Institute of Fine Chemical Recent Development Table 92. Jiangsu Lianrun Chemical Company Information Table 93. Jiangsu Lianrun Chemical Business Overview Table 94. Jiangsu Lianrun Chemical Morpholine and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Jiangsu Lianrun Chemical Morpholine and Derivatives Product Portfolio Table 96. Jiangsu Lianrun Chemical Recent Development Table 97. Nippon Nyukazai Company Information Table 98. Nippon Nyukazai Business Overview Table 99. Nippon Nyukazai Morpholine and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. Nippon Nyukazai Morpholine and Derivatives Product Portfolio Table 101. Nippon Nyukazai Recent Development Table 102. Amines & Plasticizers Company Information Table 103. Amines & Plasticizers Business Overview Table 104. Amines & Plasticizers Morpholine and Derivatives Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. Amines & Plasticizers Morpholine and Derivatives Product Portfolio Table 106. Amines & Plasticizers Recent Development Table 107. North America Morpholine and Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 108. North America Morpholine and Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 109. North America Morpholine and Derivatives Sales by Type (2021-2026) & (Tons) Table 110. North America Morpholine and Derivatives Sales by Type (2027-2032) & (Tons) Table 111. North America Morpholine and Derivatives Sales Price by Type (2021-2026) & (US$/Ton) Table 112. North America Morpholine and Derivatives Sales Price by Type (2027-2032) & (US$/Ton) Table 113. North America Morpholine and Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 114. North America Morpholine and Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 115. North America Morpholine and Derivatives Sales by Application (2021-2026) & (Tons) Table 116. North America Morpholine and Derivatives Sales by Application (2027-2032) & (Tons) Table 117. North America Morpholine and Derivatives Sales Price by Application (2021-2026) & (US$/Ton) Table 118. North America Morpholine and Derivatives Sales Price by Application (2027-2032) & (US$/Ton) Table 119. North America Morpholine and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America Morpholine and Derivatives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 121. North America Morpholine and Derivatives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 122. North America Morpholine and Derivatives Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 123. North America Morpholine and Derivatives Sales by Country (2021-2026) & (Tons) Table 124. North America Morpholine and Derivatives Sales by Country (2027-2032) & (Tons) Table 125. North America Morpholine and Derivatives Sales Price by Country (2021-2026) & (US$/Ton) Table 126. North America Morpholine and Derivatives Sales Price by Country (2027-2032) & (US$/Ton) Table 127. United States Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 128. Canada Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 129. Mexico Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 130. Europe Morpholine and Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 131. Europe Morpholine and Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 132. Europe Morpholine and Derivatives Sales by Type (2021-2026) & (Tons) Table 133. Europe Morpholine and Derivatives Sales by Type (2027-2032) & (Tons) Table 134. Europe Morpholine and Derivatives Sales Price by Type (2021-2026) & (US$/Ton) Table 135. Europe Morpholine and Derivatives Sales Price by Type (2027-2032) & (US$/Ton) Table 136. Europe Morpholine and Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 137. Europe Morpholine and Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 138. Europe Morpholine and Derivatives Sales by Application (2021-2026) & (Tons) Table 139. Europe Morpholine and Derivatives Sales by Application (2027-2032) & (Tons) Table 140. Europe Morpholine and Derivatives Sales Price by Application (2021-2026) & (US$/Ton) Table 141. Europe Morpholine and Derivatives Sales Price by Application (2027-2032) & (US$/Ton) Table 142. Europe Morpholine and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Europe Morpholine and Derivatives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 144. Europe Morpholine and Derivatives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 145. Europe Morpholine and Derivatives Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 146. Europe Morpholine and Derivatives Sales by Country (2021-2026) & (Tons) Table 147. Europe Morpholine and Derivatives Sales by Country (2027-2032) & (Tons) Table 148. Europe Morpholine and Derivatives Sales Price by Country (2021-2026) & (US$/Ton) Table 149. Europe Morpholine and Derivatives Sales Price by Country (2027-2032) & (US$/Ton) Table 150. Germany Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 151. France Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 152. U.K. Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 153. Italy Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 154. Russia Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 155. Spain Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 156. Netherlands Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 157. Switzerland Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 158. Sweden Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 159. Poland Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 160. China Morpholine and Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 161. China Morpholine and Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 162. China Morpholine and Derivatives Sales by Type (2021-2026) & (Tons) Table 163. China Morpholine and Derivatives Sales by Type (2027-2032) & (Tons) Table 164. China Morpholine and Derivatives Sales Price by Type (2021-2026) & (US$/Ton) Table 165. China Morpholine and Derivatives Sales Price by Type (2027-2032) & (US$/Ton) Table 166. China Morpholine and Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 167. China Morpholine and Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 168. China Morpholine and Derivatives Sales by Application (2021-2026) & (Tons) Table 169. China Morpholine and Derivatives Sales by Application (2027-2032) & (Tons) Table 170. China Morpholine and Derivatives Sales Price by Application (2021-2026) & (US$/Ton) Table 171. China Morpholine and Derivatives Sales Price by Application (2027-2032) & (US$/Ton) Table 172. Asia Morpholine and Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 173. Asia Morpholine and Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 174. Asia Morpholine and Derivatives Sales by Type (2021-2026) & (Tons) Table 175. Asia Morpholine and Derivatives Sales by Type (2027-2032) & (Tons) Table 176. Asia Morpholine and Derivatives Sales Price by Type (2021-2026) & (US$/Ton) Table 177. Asia Morpholine and Derivatives Sales Price by Type (2027-2032) & (US$/Ton) Table 178. Asia Morpholine and Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 179. Asia Morpholine and Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 180. Asia Morpholine and Derivatives Sales by Application (2021-2026) & (Tons) Table 181. Asia Morpholine and Derivatives Sales by Application (2027-2032) & (Tons) Table 182. Asia Morpholine and Derivatives Sales Price by Application (2021-2026) & (US$/Ton) Table 183. Asia Morpholine and Derivatives Sales Price by Application (2027-2032) & (US$/Ton) Table 184. Asia Morpholine and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. Asia Morpholine and Derivatives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. Asia Morpholine and Derivatives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. Asia Morpholine and Derivatives Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 188. Asia Morpholine and Derivatives Sales by Country (2021-2026) & (Tons) Table 189. Asia Morpholine and Derivatives Sales by Country (2027-2032) & (Tons) Table 190. Asia Morpholine and Derivatives Sales Price by Country (2021-2026) & (US$/Ton) Table 191. Asia Morpholine and Derivatives Sales Price by Country (2027-2032) & (US$/Ton) Table 192. Japan Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 193. South Korea Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 194. India Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 195. Australia Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 196. Taiwan Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 197. Southeast Asia Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 198. SAMEA Morpholine and Derivatives Revenue by Type (2021-2026) & (US$ Million) Table 199. SAMEA Morpholine and Derivatives Revenue by Type (2027-2032) & (US$ Million) Table 200. SAMEA Morpholine and Derivatives Sales by Type (2021-2026) & (Tons) Table 201. SAMEA Morpholine and Derivatives Sales by Type (2027-2032) & (Tons) Table 202. SAMEA Morpholine and Derivatives Sales Price by Type (2021-2026) & (US$/Ton) Table 203. SAMEA Morpholine and Derivatives Sales Price by Type (2027-2032) & (US$/Ton) Table 204. SAMEA Morpholine and Derivatives Revenue by Application (2021-2026) & (US$ Million) Table 205. SAMEA Morpholine and Derivatives Revenue by Application (2027-2032) & (US$ Million) Table 206. SAMEA Morpholine and Derivatives Sales by Application (2021-2026) & (Tons) Table 207. SAMEA Morpholine and Derivatives Sales by Application (2027-2032) & (Tons) Table 208. SAMEA Morpholine and Derivatives Sales Price by Application (2021-2026) & (US$/Ton) Table 209. SAMEA Morpholine and Derivatives Sales Price by Application (2027-2032) & (US$/Ton) Table 210. SAMEA Morpholine and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 211. SAMEA Morpholine and Derivatives Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 212. SAMEA Morpholine and Derivatives Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 213. SAMEA Morpholine and Derivatives Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 214. SAMEA Morpholine and Derivatives Sales by Country (2021-2026) & (Tons) Table 215. SAMEA Morpholine and Derivatives Sales by Country (2027-2032) & (Tons) Table 216. SAMEA Morpholine and Derivatives Sales Price by Country (2021-2026) & (US$/Ton) Table 217. SAMEA Morpholine and Derivatives Sales Price by Country (2027-2032) & (US$/Ton) Table 218. Brazil Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 219. Argentina Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 220. Chile Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 221. Colombia Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 222. Peru Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 223. Saudi Arabia Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 224. Israel Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 225. UAE Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 226. Turkey Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 227. Iran Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 228. Egypt Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Table 229. Key Raw Materials Table 230. Raw Materials Key Suppliers Table 231. Morpholine and Derivatives Distributors List Table 232. Morpholine and Derivatives Customers List Table 233. Research Programs/Design for This Report Table 234. Authors List of This Report Table 235. Secondary Sources Table 236. Primary Sources List of Figures Figure 1. Morpholine and Derivatives Product Image Figure 2. Global Morpholine and Derivatives Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Morpholine and Derivatives Market Size Share 2021 VS 2025 VS 2032 Figure . Morpholine Image Figure 1. N-ethylmorpholine Image Figure 2. N-methylmorpholine Image Figure 3. Other Image Figure 4. Global Morpholine and Derivatives Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 5. Global Morpholine and Derivatives Market Size Share 2021 VS 2025 VS 2032 Figure 6. Corrosion Inhibitor Image Figure 7. Pesticide Image Figure 8. Rubber Image Figure 9. Pharmaceutical Image Figure 10. Other Image Figure 11. Global Morpholine and Derivatives Capacity, Capacity Utilization (2021-2032) & (Tons) Figure 12. Global Morpholine and Derivatives Production by Region: 2021 VS 2025 VS 2032 (Tons) Figure 13. Global Morpholine and Derivatives Production Market Share by Region: 2025 Versus 2032 Figure 14. Global Morpholine and Derivatives Production Market Share by Region (2021-2032) Figure 15. North America Morpholine and Derivatives Production Growth Rate (2021-2032) & (Tons) Figure 16. Europe Morpholine and Derivatives Production Growth Rate (2021-2032) & (Tons) Figure 17. China Morpholine and Derivatives Production Growth Rate (2021-2032) & (Tons) Figure 18. Japan Morpholine and Derivatives Production Growth Rate (2021-2032) & (Tons) Figure 19. Global Morpholine and Derivatives Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 20. Global Morpholine and Derivatives Revenue (2021-2032) & (US$ Million) Figure 21. Global Morpholine and Derivatives Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Morpholine and Derivatives Revenue Market Share by Region: 2025 Versus 2032 Figure 23. Global Morpholine and Derivatives Revenue Market Share by Region (2021-2032) Figure 24. Global Morpholine and Derivatives Sales (2021-2032) & (Tons) Figure 25. Global Morpholine and Derivatives Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 26. Global Morpholine and Derivatives Sales Market Share by Region (2021-2032) Figure 27. North America Morpholine and Derivatives Sales YoY (2021-2032) & (Tons) Figure 28. Europe Morpholine and Derivatives Sales YoY (2021-2032) & (Tons) Figure 29. China Morpholine and Derivatives Sales YoY (2021-2032) & (Tons) Figure 30. Asia (Excluding China) Morpholine and Derivatives Sales YoY (2021-2032) & (Tons) Figure 31. South America, Middle East and Africa Morpholine and Derivatives Sales YoY (2021-2032) & (Tons) Figure 32. Global Morpholine and Derivatives Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 33. Global Morpholine and Derivatives Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 34. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 35. Global Morpholine and Derivatives Revenue Market Share by Type (2021-2032) Figure 36. Global Morpholine and Derivatives Sales Market Share by Type (2021-2032) Figure 37. Global Morpholine and Derivatives Revenue Market Share by Application (2021-2032) Figure 38. Global Morpholine and Derivatives Sales Market Share by Application (2021-2032) Figure 39. North America Morpholine and Derivatives Revenue Share by Type (2021-2032) Figure 40. North America Morpholine and Derivatives Sales Share by Type (2021-2032) Figure 41. North America Morpholine and Derivatives Revenue Share by Application (2021-2032) Figure 42. North America Morpholine and Derivatives Sales Share by Application (2021-2032) Figure 43. North America Morpholine and Derivatives Revenue Share by Country (2021-2032) Figure 44. North America Morpholine and Derivatives Sales Share by Country (2021-2032) Figure 45. Europe Morpholine and Derivatives Revenue Share by Type (2021-2032) Figure 46. Europe Morpholine and Derivatives Sales Share by Type (2021-2032) Figure 47. Europe Morpholine and Derivatives Revenue Share by Application (2021-2032) Figure 48. Europe Morpholine and Derivatives Sales Share by Application (2021-2032) Figure 49. Europe Morpholine and Derivatives Revenue Share by Country (2021-2032) Figure 50. Europe Morpholine and Derivatives Sales Share by Country (2021-2032) Figure 51. China Morpholine and Derivatives Revenue Share by Type (2021-2032) Figure 52. China Morpholine and Derivatives Sales Share by Type (2021-2032) Figure 53. China Morpholine and Derivatives Revenue Share by Application (2021-2032) Figure 54. China Morpholine and Derivatives Sales Share by Application (2021-2032) Figure 55. Asia Morpholine and Derivatives Revenue Share by Type (2021-2032) Figure 56. Asia Morpholine and Derivatives Sales Share by Type (2021-2032) Figure 57. Asia Morpholine and Derivatives Revenue Share by Application (2021-2032) Figure 58. Asia Morpholine and Derivatives Sales Share by Application (2021-2032) Figure 59. Asia Morpholine and Derivatives Revenue Share by Country (2021-2032) Figure 60. Asia Morpholine and Derivatives Sales Share by Country (2021-2032) Figure 61. SAMEA Morpholine and Derivatives Revenue Share by Type (2021-2032) Figure 62. SAMEA Morpholine and Derivatives Sales Share by Type (2021-2032) Figure 63. SAMEA Morpholine and Derivatives Revenue Share by Application (2021-2032) Figure 64. SAMEA Morpholine and Derivatives Sales Share by Application (2021-2032) Figure 65. SAMEA Morpholine and Derivatives Revenue Share by Country (2021-2032) Figure 66. SAMEA Morpholine and Derivatives Sales Share by Country (2021-2032) Figure 67. Morpholine and Derivatives Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Morpholine and Derivatives Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Morpholine
  • N-ethylmorpholine
  • N-methylmorpholine
  • Other
Applications
  • Corrosion Inhibitor
  • Pesticide
  • Rubber
  • Pharmaceutical
  • Other
Companies covered
  • Huntsman
  • Anhui Wotu Chemical
  • BASF
  • Jiangsu Dingsheng Chemical
  • Liyang Yutian Chemical
  • Sichuan Institute of Fine Chemical
  • Jiangsu Lianrun Chemical
  • Nippon Nyukazai
  • Amines & Plasticizers

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Morpholine and Derivatives Market by Type
  3. 1.2.1 Global Morpholine and Derivatives Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Morpholine
  5. 1.2.3 N-ethylmorpholine
  6. 1.2.4 N-methylmorpholine
  7. 1.2.5 Other
  8. 1.3 Morpholine and Derivatives Market by Application
  9. 1.3.1 Global Morpholine and Derivatives Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Corrosion Inhibitor
  11. 1.3.3 Pesticide
  12. 1.3.4 Rubber
  13. 1.3.5 Pharmaceutical
  14. 1.3.6 Other
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Morpholine and Derivatives Market Dynamics
  1. 2.1 Morpholine and Derivatives Industry Trends
  2. 2.2 Morpholine and Derivatives Industry Drivers
  3. 2.3 Morpholine and Derivatives Industry Opportunities and Challenges
  4. 2.4 Morpholine and Derivatives Industry Restraints
3 Global Morpholine and Derivatives Production Overview
  1. 3.1 Global Morpholine and Derivatives Production Capacity (2021-2032)
  2. 3.2 Global Morpholine and Derivatives Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Morpholine and Derivatives Production by Region
  4. 3.3.1 Global Morpholine and Derivatives Production by Region (2021-2026)
  5. 3.3.2 Global Morpholine and Derivatives Production by Region (2027-2032)
  6. 3.3.3 Global Morpholine and Derivatives Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Morpholine and Derivatives Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Morpholine and Derivatives Revenue by Region
  3. 4.2.1 Global Morpholine and Derivatives Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Morpholine and Derivatives Revenue by Region (2021-2026)
  5. 4.2.3 Global Morpholine and Derivatives Revenue by Region (2027-2032)
  6. 4.2.4 Global Morpholine and Derivatives Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Morpholine and Derivatives Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Morpholine and Derivatives Sales by Region
  9. 4.4.1 Global Morpholine and Derivatives Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Morpholine and Derivatives Sales by Region (2021-2026)
  11. 4.4.3 Global Morpholine and Derivatives Sales by Region (2027-2032)
  12. 4.4.4 Global Morpholine and Derivatives Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Morpholine and Derivatives Revenue by Manufacturers
  2. 5.1.1 Global Morpholine and Derivatives Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Morpholine and Derivatives Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Morpholine and Derivatives Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Morpholine and Derivatives Sales by Manufacturers
  6. 5.2.1 Global Morpholine and Derivatives Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Morpholine and Derivatives Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Morpholine and Derivatives Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Morpholine and Derivatives Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Morpholine and Derivatives Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Morpholine and Derivatives Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Morpholine and Derivatives Manufacturers, Product Type & Application
  13. 5.7 Global Morpholine and Derivatives Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Morpholine and Derivatives Market CR5 and HHI
  16. 5.8.2 2025 Morpholine and Derivatives Tier 1, Tier 2, and Tier 3
6 Morpholine and Derivatives Market by Type
  1. 6.1 Global Morpholine and Derivatives Revenue by Type
  2. 6.1.1 Global Morpholine and Derivatives Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Morpholine and Derivatives Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Morpholine and Derivatives Sales by Type
  5. 6.2.1 Global Morpholine and Derivatives Sales by Type (2021-2032) & (Tons)
  6. 6.2.2 Global Morpholine and Derivatives Sales Market Share by Type (2021-2032)
  7. 6.3 Global Morpholine and Derivatives Price by Type
7 Morpholine and Derivatives Market by Application
  1. 7.1 Global Morpholine and Derivatives Revenue by Application
  2. 7.1.1 Global Morpholine and Derivatives Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Morpholine and Derivatives Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Morpholine and Derivatives Sales by Application
  5. 7.2.1 Global Morpholine and Derivatives Sales by Application (2021-2032) & (Tons)
  6. 7.2.2 Global Morpholine and Derivatives Sales Market Share by Application (2021-2032)
  7. 7.3 Global Morpholine and Derivatives Price by Application
8 Company Profiles
  1. 8.1 Huntsman
  2. 8.1.1 Huntsman Company Information
  3. 8.1.2 Huntsman Business Overview
  4. 8.1.3 Huntsman Morpholine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 Huntsman Morpholine and Derivatives Product Portfolio
  6. 8.1.5 Huntsman Recent Developments
  7. 8.2 Anhui Wotu Chemical
  8. 8.2.1 Anhui Wotu Chemical Company Information
  9. 8.2.2 Anhui Wotu Chemical Business Overview
  10. 8.2.3 Anhui Wotu Chemical Morpholine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Anhui Wotu Chemical Morpholine and Derivatives Product Portfolio
  12. 8.2.5 Anhui Wotu Chemical Recent Developments
  13. 8.3 BASF
  14. 8.3.1 BASF Company Information
  15. 8.3.2 BASF Business Overview
  16. 8.3.3 BASF Morpholine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 BASF Morpholine and Derivatives Product Portfolio
  18. 8.3.5 BASF Recent Developments
  19. 8.4 Jiangsu Dingsheng Chemical
  20. 8.4.1 Jiangsu Dingsheng Chemical Company Information
  21. 8.4.2 Jiangsu Dingsheng Chemical Business Overview
  22. 8.4.3 Jiangsu Dingsheng Chemical Morpholine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 Jiangsu Dingsheng Chemical Morpholine and Derivatives Product Portfolio
  24. 8.4.5 Jiangsu Dingsheng Chemical Recent Developments
  25. 8.5 Liyang Yutian Chemical
  26. 8.5.1 Liyang Yutian Chemical Company Information
  27. 8.5.2 Liyang Yutian Chemical Business Overview
  28. 8.5.3 Liyang Yutian Chemical Morpholine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 8.5.4 Liyang Yutian Chemical Morpholine and Derivatives Product Portfolio
  30. 8.5.5 Liyang Yutian Chemical Recent Developments
  31. 8.6 Sichuan Institute of Fine Chemical
  32. 8.6.1 Sichuan Institute of Fine Chemical Company Information
  33. 8.6.2 Sichuan Institute of Fine Chemical Business Overview
  34. 8.6.3 Sichuan Institute of Fine Chemical Morpholine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 8.6.4 Sichuan Institute of Fine Chemical Morpholine and Derivatives Product Portfolio
  36. 8.6.5 Sichuan Institute of Fine Chemical Recent Developments
  37. 8.7 Jiangsu Lianrun Chemical
  38. 8.7.1 Jiangsu Lianrun Chemical Company Information
  39. 8.7.2 Jiangsu Lianrun Chemical Business Overview
  40. 8.7.3 Jiangsu Lianrun Chemical Morpholine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 8.7.4 Jiangsu Lianrun Chemical Morpholine and Derivatives Product Portfolio
  42. 8.7.5 Jiangsu Lianrun Chemical Recent Developments
  43. 8.8 Nippon Nyukazai
  44. 8.8.1 Nippon Nyukazai Company Information
  45. 8.8.2 Nippon Nyukazai Business Overview
  46. 8.8.3 Nippon Nyukazai Morpholine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 8.8.4 Nippon Nyukazai Morpholine and Derivatives Product Portfolio
  48. 8.8.5 Nippon Nyukazai Recent Developments
  49. 8.9 Amines & Plasticizers
  50. 8.9.1 Amines & Plasticizers Company Information
  51. 8.9.2 Amines & Plasticizers Business Overview
  52. 8.9.3 Amines & Plasticizers Morpholine and Derivatives Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 8.9.4 Amines & Plasticizers Morpholine and Derivatives Product Portfolio
  54. 8.9.5 Amines & Plasticizers Recent Developments
9 North America
  1. 9.1 North America Morpholine and Derivatives Market Size by Type
  2. 9.1.1 North America Morpholine and Derivatives Revenue by Type (2021-2032)
  3. 9.1.2 North America Morpholine and Derivatives Sales by Type (2021-2032)
  4. 9.1.3 North America Morpholine and Derivatives Price by Type (2021-2032)
  5. 9.2 North America Morpholine and Derivatives Market Size by Application
  6. 9.2.1 North America Morpholine and Derivatives Revenue by Application (2021-2032)
  7. 9.2.2 North America Morpholine and Derivatives Sales by Application (2021-2032)
  8. 9.2.3 North America Morpholine and Derivatives Price by Application (2021-2032)
  9. 9.3 North America Morpholine and Derivatives Market Size by Country
  10. 9.3.1 North America Morpholine and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Morpholine and Derivatives Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Morpholine and Derivatives Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Morpholine and Derivatives Market Size by Type
  2. 10.1.1 Europe Morpholine and Derivatives Revenue by Type (2021-2032)
  3. 10.1.2 Europe Morpholine and Derivatives Sales by Type (2021-2032)
  4. 10.1.3 Europe Morpholine and Derivatives Price by Type (2021-2032)
  5. 10.2 Europe Morpholine and Derivatives Market Size by Application
  6. 10.2.1 Europe Morpholine and Derivatives Revenue by Application (2021-2032)
  7. 10.2.2 Europe Morpholine and Derivatives Sales by Application (2021-2032)
  8. 10.2.3 Europe Morpholine and Derivatives Price by Application (2021-2032)
  9. 10.3 Europe Morpholine and Derivatives Market Size by Country
  10. 10.3.1 Europe Morpholine and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Morpholine and Derivatives Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Morpholine and Derivatives Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Morpholine and Derivatives Market Size by Type
  2. 11.1.1 China Morpholine and Derivatives Revenue by Type (2021-2032)
  3. 11.1.2 China Morpholine and Derivatives Sales by Type (2021-2032)
  4. 11.1.3 China Morpholine and Derivatives Price by Type (2021-2032)
  5. 11.2 China Morpholine and Derivatives Market Size by Application
  6. 11.2.1 China Morpholine and Derivatives Revenue by Application (2021-2032)
  7. 11.2.2 China Morpholine and Derivatives Sales by Application (2021-2032)
  8. 11.2.3 China Morpholine and Derivatives Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Morpholine and Derivatives Market Size by Type
  2. 12.1.1 Asia Morpholine and Derivatives Revenue by Type (2021-2032)
  3. 12.1.2 Asia Morpholine and Derivatives Sales by Type (2021-2032)
  4. 12.1.3 Asia Morpholine and Derivatives Price by Type (2021-2032)
  5. 12.2 Asia Morpholine and Derivatives Market Size by Application
  6. 12.2.1 Asia Morpholine and Derivatives Revenue by Application (2021-2032)
  7. 12.2.2 Asia Morpholine and Derivatives Sales by Application (2021-2032)
  8. 12.2.3 Asia Morpholine and Derivatives Price by Application (2021-2032)
  9. 12.3 Asia Morpholine and Derivatives Market Size by Country
  10. 12.3.1 Asia Morpholine and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Morpholine and Derivatives Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Morpholine and Derivatives Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Morpholine and Derivatives Market Size by Type
  2. 13.1.1 SAMEA Morpholine and Derivatives Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Morpholine and Derivatives Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Morpholine and Derivatives Price by Type (2021-2032)
  5. 13.2 SAMEA Morpholine and Derivatives Market Size by Application
  6. 13.2.1 SAMEA Morpholine and Derivatives Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Morpholine and Derivatives Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Morpholine and Derivatives Price by Application (2021-2032)
  9. 13.3 SAMEA Morpholine and Derivatives Market Size by Country
  10. 13.3.1 SAMEA Morpholine and Derivatives Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Morpholine and Derivatives Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Morpholine and Derivatives Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Morpholine and Derivatives Value Chain Analysis
  2. 14.1.1 Morpholine and Derivatives Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Morpholine and Derivatives Production Mode & Process
  6. 14.2 Morpholine and Derivatives Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Morpholine and Derivatives Distributors
  9. 14.2.3 Morpholine and Derivatives Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst